Cefoperazone/sulbactam in the treatment of respiratoryinfections 175 cases of clinical observation
Mei Yu-zhen
Abstract
Mei Yu-zhen
Abstract
Cefoperazone/sulbactam in the treatment of respiratory infections efficacy and safety.Methods: January 2006-December 2010 175 cases of cefoperazone/sulbactam in the treatment of respiratory infections were studied retrospectively to summarize the efficacy and toxicity.The results of cefoperazone/sulbactam dosage daily 2g ~ 4g,course of 5 to 18 days;3 to 6.5 days after treatment decreased body temperature,body temperature decreased rate of 92.0%;white blood cell count increased by 85.4% after treatment to normal range,52.6% of X-ray findings of inflammatory disappeared or significantly improved absorption,sputum bacterial culture positive bacterial clearance rate was 85.1%;total effective rate was 86.9%,ineffective in 12 cases of severe neutropenia;16 patients alanyl transient increase in acid transaminase,I was no other side effects.Conclusion: cefoperazone/sulbactam in the treatment of respiratory infections safety effect.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cefoperazone/sulbactam in the treatment of respiratory infections efficacy and safety.Methods: January 2006-December 2010 175 cases of cefoperazone/sulbactam in the treatment of respiratory infections were studied retrospectively to summarize the efficacy and toxicity.The results of cefoperazone/sulbactam dosage daily 2g ~ 4g,course of 5 to 18 days;3 to 6.5 days after treatment decreased body temperature,body temperature decreased rate of 92.0%;white blood cell count increased by 85.4% after treatment to normal range,52.6% of X-ray findings of inflammatory disappeared or significantly improved absorption,sputum bacterial culture positive bacterial clearance rate was 85.1%;total effective rate was 86.9%,ineffective in 12 cases of severe neutropenia;16 patients alanyl transient increase in acid transaminase,I was no other side effects.Conclusion: cefoperazone/sulbactam in the treatment of respiratory infections safety effect.
Key concepts: Cefoperazone, Medicine, Sulbactam, Neutropenia, Gastroenterology, White blood cell, Sputum, Internal medicine